Park Medi World share price, P/E, ROE & financials

Park Medi World (PARKHOSPS) had a P/E of 38.3× on 6 Nov 2026, below the industry P/E of 47.7×, and the shares are 18% below their 52-week high. Sales and net profit grew 9.6% and 5.5% a year over 3 years; its ROCE of 18% is the second-highest among the 7 largest Medical Care Facilities peers. Debt is 0.17× equity. It is a small-cap company with a market cap of ₹10,858 Cr, ranked 10th of 40 Medical Care Facilities companies by market cap; the shares rose 70% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹244.01
Day high: ₹253.44
Day low: ₹231.21
Prev. close: ₹244.57
Volume: 6.5 L

Health check

3 good · 2 fair · 1 to check

ReturnsAhead
+69.9% over a year, better than 7 of 7 peers.
Price tagCheaper
P/E 38.3 vs industry 47.7.
GrowthSlow
Sales +9.6%, profit +5.5% a year over 3 years.
ProfitabilityAverage
ROCE 17.9% vs peer median 11.9%.
Balance sheetFair
Debt 0.17× equity, interest covered 7.5×, Piotroski 5 of 9.
Red flagsNone found
No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹10,858 Cr, #10 of 40 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹1,756 Cr · profit ₹283 Cr

Market cap: ₹10,858 Cr; Small cap
P/E: 38.3; Industry 47.7
Price to book: 4.95; Peers 8.06
Dividend yield: 0.00%
ROE: 16.8%; Peers 12.8%
ROCE: 17.9%; Peers 11.9%
Debt to equity: 0.17; Debt ₹364 Cr
EPS (TTM): ₹6.57; Face value ₹2
OPM (TTM): 26.8%; Net margin 16.1%
Sales growth: +19.3%; Latest quarter vs a year ago
Profit growth: +42.3%; Latest quarter vs a year ago
Price to sales: 6.18; EV/EBITDA 21.8

Strengths

Quarterly profit up 42.3% on a year ago.
Quarterly sales up 19.3% on a year ago.
Positive operating cash flow in each of the last 4 years.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Park Medi World

Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology,…

Headquarters: Gurugram
Employees: 6,423
Sector: Healthcare
ISIN: INE119201023
Website: parkhospital.in

Price range

52 weeks

₹138.10₹305.00

Today

₹231.21₹253.44

Avg volume (3M): 6.8 L
1-year return: plus 69.9%
From 52-week high: minus 17.6%

Peers · Medical Care Facilities

Compare with peers Screen the whole industry

Company
APOLLOHOSPApollo Hospitals Enterprise	8,446.00	plus 0.90%	1,21,441	54.0	11.45	19.2%	22.5%	15.4%	14.8%	33.3%	0.24%	plus 7.2%
MAXHEALTHMax Healthcare Institute	934.00	plus 0.21%	90,909	66.1	8.03	12.6%	12.8%	26.8%	22.4%	9.3%	0.21%	minus 18.1%
MANIPALHOSManipal Health Enterprises	646.70	minus 1.61%	85,065	133.6	9.05	9.8%	9.2%	17.8%	–	–	0.00%	minus 3.0%
ASTERDMAster DM Quality Care	713.15	minus 0.89%	62,092	90.7	8.06	9.4%	9.7%	17.4%	15.7%	−3.0%	0.42%	plus 4.5%
FORTISFortis Healthcare	766.90	minus 6.45%	57,898	55.7	5.52	11.9%	10.4%	22.2%	13.3%	20.9%	0.13%	minus 19.6%
NHNarayana Hrudayalaya	1,903.00	minus 0.65%	38,650	44.7	7.73	11.4%	19.1%	18.5%	20.5%	9.9%	0.24%	plus 4.7%
MEDANTAGlobal Health	1,387.60	minus 0.15%	37,264	60.4	8.63	15.0%	15.2%	22.1%	17.2%	19.5%	0.04%	plus 11.2%
PARKHOSPSPark Medi World	251.39	plus 2.79%	10,858	38.3	4.95	17.9%	16.8%	22.5%	9.6%	5.5%	0.00%	plus 69.9%
Median of 7 peers	–	−0.65%	62,092	60.4	8.06	11.9%	12.8%	18.5%	16.5%	14.7%	0.21%	4.5%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
399	403	410	460	476
294	288	311	333	350
105	115	99.4	127	126
26.3%	28.6%	24.2%	27.7%	26.5%
6.9	6.4	9.1	7.5	7.6
15.1	13.9	14.9	14	9.8
14.8	13.5	15.3	17.5	18.8
–	−2.2	–	–	–
81.9	92	78.3	103	105
20.0%	20.0%	32.5%	25.7%	15.7%
58	74	50.8	70.9	82.5
1.34	–	1.35	1.64	2.05

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +9.6%
Profit CAGR 3Y: +5.5%
EPS CAGR 3Y: +10.5%
ROE: 16.8%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
1,252	1,229	1,392	1,651
–	minus 1.9%	+13.2%	+18.6%
840	909	1,018	1,204
412	320	374	446
32.9%	26.1%	26.9%	27.0%
15.2	27.8	27.3	24.3
49.2	69.5	59.6	54.4
40.5	50.6	56.9	62.5
−22.9	−9.8	0.8	0.8
315	218	286	355
27.6%	30.3%	24.6%	22.9%
220	153	202	258
–	minus 30.1%	+31.4%	+28.0%
5.09	3.55	4.67	6.87

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
76.9	76.9	76.9	86.4
610	806	975	1,936
576	687	682	364
331	343	405	427
1,593	1,912	2,139	2,813
481	793	819	1,050
22.4	33.7	48	132
101	9	51.3	120
203	390	361	431
786	686	860	1,081
1,593	1,912	2,139	2,813

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
195	361	215	329
−180	−255	−100	−333
1.5	−130	−88.9	121
16.9	−23.4	26.4	116
−98.4	−71.5	−145	−120
96.6	290	70.3	209

Shareholding pattern

Source: NSE filings

82.9%

promoters

Promoters82.90%
Public17.10%
As of 30 Sep 2026

Quarter	Promoters	Public	Promoter change
30 Sep 2026	82.90%	17.10%	plus 0.01
30 Jun 2026	82.89%	17.11%	0.00
31 Mar 2026	82.89%	17.11%	0.00
31 Dec 2025	82.89%	17.11%	0.00
16 Dec 2025	82.89%	17.11%	–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you